GSK’s Move to Cambridge Leaves Stevenage Facing an Uncertain Future
GSK’s decision to move its main research and development operation from Stevenage to Cambridge is creating uncertainty for a town ...
GSK’s decision to move its main research and development operation from Stevenage to Cambridge is creating uncertainty for a town ...
Eli Lilly is escalating its campaign against the growing black market for retatrutide, its experimental obesity drug, filing six lawsuits ...
Pharmaceutical giant increases its full-year revenue guidance after reporting strong demand for its blockbuster obesity and diabetes treatments, reinforcing confidence ...